BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE | A205397 | PADAGIS ISRAEL PHARMACEUTICALS LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
DOW PHARMACEUTICAL SCIENCES, INC. et al v. PERRIGO COMPANY et al 1 patentANDA 205397clindamycin phosphate and benzoyl peroxide | D.N.J. | 2013-11-15 | Terminated 2014-08-28 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$0.7668
per gm
Lowest NADAC/Unit
$0.7668
per gm
Brand NDCs
0
Generic NDCs
1
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 45802059701CLIND PH-BENZOYL PERO 1.2-2.5% | $0.7668 | GM | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.